The emerging role of proactive therapy in atopic dermatitis and psoriasis
Authors:
- Justyna PiętaJPJustyna Pięta
- Marcel ChudzikowskiMCMarcel Chudzikowski
- Patryk DudekPDPatryk Dudek
- Klaudia ŁuczakKŁKlaudia Łuczak
- Agnieszka PawlikAPAgnieszka Pawlik
- Agata ProkopiukAPAgata Prokopiuk
- Joanna PrusJPJoanna Prus
- Adrianna TabeauATAdrianna Tabeau
- Wiktoria UlickaWUWiktoria Ulicka
- Hanna SitarekHSHanna Sitarek
Open Access
- 26 April 2025
- journal article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 59456
Abstract
Proactive therapy represents an evolving approach in the long-term management of atopic dermatitis (AD) and psoriasis. Unlike reactive treatment, which targets active symptoms, proactive therapy involves the intermittent, low-dose application of anti-inflammatory agents to previously affected but clinically healed skin to prevent flare-ups. This strategy aims to reduce subclinical inflammation, extend remission periods, and improve patient quality of life. A growing body of evidence supports the efficacy of proactive treatment with topical corticosteroids, calcineurin inhibitors, and vitamin D analogues, demonstrating significant reductions in relapse rates and treatment costs. However, patient adherence remains a key challenge, necessitating structured follow-up and patient education initiatives. This review explores the pathophysiological basis of proactive therapy, its clinical applications, and current evidence supporting its role in AD and psoriasis management. Additionally, we discuss safety concerns, particularly regarding skin atrophy and hypothalamic-pituitary-adrenal axis suppression, and highlight emerging therapeutic options. While proactive therapy has demonstrated a favourable benefit-risk profile, further studies are needed to refine treatment protocols and expand its application to broader patient populations.Keywords
This publication has 39 references indexed in Scilit:
- Update on the pathogenesis of atopic dermatitisAnais Brasileiros de Dermatologia, 2024
- The Immunology of Psoriasis—Current Concepts in PathogenesisClinical Reviews in Allergy & Immunology, 2024
- Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trialsJournal of Allergy and Clinical Immunology, 2023
- Update on the Pathogenesis and Therapy of Atopic DermatitisClinical Reviews in Allergy & Immunology, 2021
- Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and ConsAmerican Journal of Clinical Dermatology, 2021
- Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial)Journal of the American Academy of Dermatology, 2021
- Atopic dermatitisThe Lancet, 2020
- Pathophysiology, Clinical Presentation, and Treatment of PsoriasisJAMA, 2020
- Proactive treatment in childhood psoriasisAnnales de Dermatologie et de Vénéréologie, 2020
- Skin Colonization by Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic Dermatitis in InfancyJournal of Investigative Dermatology, 2017